Alteration of SHP-1/p-STAT3 Signaling: A Potential Target for Anticancer Therapy. [electronic resource]
Producer: 20180326ISSN:- 1422-0067
- Animals
- Antineoplastic Agents -- pharmacology
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Humans
- Molecular Targeted Therapy
- Neoplasms -- drug therapy
- Phosphorylation
- Protein Tyrosine Phosphatase, Non-Receptor Type 6 -- antagonists & inhibitors
- STAT3 Transcription Factor -- metabolism
- Signal Transduction -- drug effects
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.